Diffusion Pharmaceuticals http://www.diffusionpharma.com Mon, 06 Feb 2012 14:39:17 +0000 en hourly 1 http://wordpress.org/?v=3.1 Diffusion Pharmaceuticals Receives FDA Orphan Status for TSC, a First-in-Class Drug for the Treatment of Primary Brain Cancer http://www.diffusionpharma.com/research/fda-grants-orphan-drug-status-for-tsc-in-cancer http://www.diffusionpharma.com/research/fda-grants-orphan-drug-status-for-tsc-in-cancer#comments Tue, 26 Jul 2011 14:32:05 +0000 Tracey Danner http://www.diffusionpharma.com/?p=427 http://www.diffusionpharma.com/research/fda-grants-orphan-drug-status-for-tsc-in-cancer/feed 0 Diffusion Pharmaceuticals Closes on $2.2 Million Financing; Plans Clinical Trial In Primary Brain Cancer http://www.diffusionpharma.com/progress/closes-on-2-2-million-financing-plans-clinical-trial-in-primary-brain-cancer http://www.diffusionpharma.com/progress/closes-on-2-2-million-financing-plans-clinical-trial-in-primary-brain-cancer#comments Sun, 01 May 2011 15:04:02 +0000 Tracey Danner http://www.diffusionpharma.com/?p=439 http://www.diffusionpharma.com/progress/closes-on-2-2-million-financing-plans-clinical-trial-in-primary-brain-cancer/feed 0 Diffusion Pharmaceuticals Achieves Positive Results in Phase I/II Clinical Trial of Trans Sodium Crocetinate in Peripheral Artery Disease; Drug Offers Promise for Range of Serious Hypoxia-Related Medical Conditions http://www.diffusionpharma.com/research/diffusion-pharmaceuticals-achieves-positive-results-in-phase-iii-clinical-trial-of-trans-sodium-crocetinate-in-peripheral-artery-disease-drug-offers-promise-for-range-of-serious-hypoxia-related-medi http://www.diffusionpharma.com/research/diffusion-pharmaceuticals-achieves-positive-results-in-phase-iii-clinical-trial-of-trans-sodium-crocetinate-in-peripheral-artery-disease-drug-offers-promise-for-range-of-serious-hypoxia-related-medi#comments Mon, 15 Nov 2010 20:30:37 +0000 Tracey Danner http://www.diffusionpharma.com/?p=358 http://www.diffusionpharma.com/research/diffusion-pharmaceuticals-achieves-positive-results-in-phase-iii-clinical-trial-of-trans-sodium-crocetinate-in-peripheral-artery-disease-drug-offers-promise-for-range-of-serious-hypoxia-related-medi/feed 0